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Abdract The three-dimensional solution structure of the leech derived tryptase inhibitor form C (LDTI-C), an inhibitor of 46 amino acids which 
contains 3 disultide bridges, has been determined using 2D NMR spectroscopy. The 3D structure was determined on the basis of 262 interresidue 
interproton distance constraints derived from nuclear Overhauser enhancement measurements and 25 $ angles, supplemented by 3 Q, and 15~~ angles. 
The core of LDTI-C is very well de&d and consists of a short 3,,-helix-loop and a short two-stranded antiparallel B-sheet between residues 13-14 
and 20-21. The N-terminus is fixed to the core by two disulBde bridges, while the C-terminus is connected to the,!?-sheet via the third disulflde bridge. 
The binding loop in LDTI exhibits lowest energy conformations belonging to the canonical conformation of serine proteinase inhibitors. 
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1. lntrodnctlon 
The actual physiological functions of the human tryptase, a 
tetrameric trypsin-like serine proteinase from mast cells, remain 
to be clarified (for a review see [l]). In vitro studies suggest hat 
the enzyme is involved in the catabolism of extracellular matrix 
proteins [2], in coagulation [3], and in neuropeptide turnover 
[4]. Furthermore, a pathogenetic role of tryptase in allergic 
reactions and destruction of cartilage as in asthma [!I’l, rheuma- 
toid arthritis [q, fibrosis [7’J, artherosclerosis [8], scleroderma 
[9], anaphylaxis, and mastocytosis [lo], has been implicated. 
Recently, Sommerhoff et al. [ 1 l] isolated, purified, and char- 
acterized new small proteins from Hirudo medicinalis which 
inhibit human tryptase. Three forms were described, designated 
LDTI-A, LDTI-B, and LDTI-C. Form A, the shortest one, is 
42 amino acids long and could not be separated from form B, 
which contains an additional C-terminal Gly. Form C contains 
46 amino acids and has a molecular mass of 4738 Da [l 1,121. 
This form is the subject of our 2D NMR structure determina- 
tion. 
An amino acid sequence comparison of LDTI with other 
protein inhibitors shows ca. 40% homology of LDTI to Kazal- 
type inhibitors (ovomucoids), such as turkey ovomucoid 3rd 
domain (OMTKY3), porcine pancreatic trypsin inhibitor 
(PSTI), and to the both domains of the Kazal-type-like 
rhodniin [13], with highest similarity to the non-classical Kazal- 
type inhibitor bdellin B3 [14]. Rhodniin and bdellin B3 differ 
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from the classical Kazal type inhibitors by their shortened NH- 
terminal sequences and by one or two internal deletions, respec- 
tively. The high identity of these primary structures implied 
similar 3D structures. Threedimensional structures of several 
Kazal type inhibitors are known [15], providing a basis for 
models, for example, of bdellin B3 and rhodniin [13,14]. Com- 
mon motifs of the experimentally determined and modeled 
structures are the exposed ‘canonical’ binding loop [15], the two 
to three turn a-helix, and a short three-stranded anti-parallel 
B-sheet. Distinct differences among the structures are found at 
the N-termini and at segments connecting the helix with the 
third B-strand. 
In this paper, we describe the three-dimensional structure of 
LDTI-C in solution as determined by 2D NMR. 
2. Experimental 
A synthetic gene coding for form C of LDTI was designed, cloned 
and expressed in Saccharomyces cerevisiae. The secreted material was 
isolated after cross-flow tiltration and purified by cation exchange 
chromatography, it is inhibitorily active and about 85% pure [12]. The 
samule for NMR contained -3 mM LDTI-C in 50 mM NaH,POJ 
CD&ONa buffer @H 3.5) in 90% H20/10%D20. In addition: one 
sample was prepared in 100% D,O. 
NMR measurements were carried out at 500 MHz and 600 MHz on 
the Bruker AM-500 and AMX-600 spectrometer, respectively. The 
following 2D ‘H-‘H NMR spectra were recorded in Hz0 and DZO: 
NOESY 1161 with mixinn times of 80 and 100 ms. and TOCSY 117.181 
with a MLEV-17 mixing sequence [19] of 50 ms ‘duration. The’DQF: 
COSY spectrum in Hz0 and in D,O were also acquired [20]. All spectra 
were measured at 27°C. For the NOESY spectra in H,O, the water 
resonance was suppressed by the use of a semi-selective excitation pulse 
in which the last 90” pulse in the sequence was replaced by the jump- 
return sequence with the carrier placed at the position of water [21]. For 
the TOCSY and DQF-COSY spectra in H,O, the water resonance was 
suppressed by presaturation of the water resonance. For most of the 
spectra, 700 tl increments were collected, each with 4K data points, over 
a spectral width of 6 kHz in both dimensions. 3Jme coupling constants 
were measured from DQF-COSY spectra in H,O. The apparent ‘Ju,.,. 
coupling constants, measured from the splittings of the NH-C”H cross- 
peaks, were corrected for line width using a method of Kim and Pre- 
stegard [22]. For stereospecific assignment, ?I@ were extracted from the 
DQF-COSY in D,O. Stereospecific assigmnems of @I-I protons and 
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methyl groups of valines and leucines were obtained using procedures 
described bv Waaner et al. 1231 and Hvberts et al. 1241. An amide 
exchange xperim&t, consisting bf a series of 2D NOESY experiments, 
was carried out with LDTI-C lyophilixed from water buffer and then 
freshly dissolved in DtO. Within 24 h, three 2D datasets were recorded. 
Structure calculations were carried out essentially according to the 
basic protocol described previously [25]. NOES were derived from the 
2D NOESY spectra in H,O and D,O at mixing times of 80 and 100 ms, 
respectively. The intensities of the 2D NOE cross peaks were classified 
as very strong, strong, medium, weak-medium and weak and converted 
into distance constraints. A complete list of NOE interproton, hydro- 
gen-bonding distance constraints and torsion angle constraints, as well 
as coordinates of the structures are available from the authors. The 
distance constraint data were supplemented with 25 4 torsion angle 
constraints derived from the ‘JHN, coupling constant data and 3 Q, 
angles (for the tranr-peptide bond of the X-Pro residues [26]). d con- 
straints (-120 + 40’) were introduced corresponding to ‘Jma coupling 
constants larger than 8 Hz [271. Stereospecific assignments were ob- 
mined for 15 of the 86 prochiral centers of LDTI. For the final refme- 
ment, the NOE tables were supplemented with the # constraints derived 
for coupling constants equal to 8 Hz and 5 6 Hz [25]. These ) con- 
straints were introduced for residues for which d’s were close to the 
mean value (within + 10”) and fulfilled the Karplus relationship [271 
in structures calculated without the dihedral constraints. Two hydrogen 
bonds identified on the basis of the examination of the structures during 
the secondary structure analysis were also introduced. In addition, 25 
non-NOE constraints were included in the calculations [25]. 
The distance bounds of the distance constraints were set to d ?r 0.3 
A for the distance constraints between 2.3-2.7 A (very and stron 
NOES), to d + 0.4 A for the distance constraints between 2.8-3.6 %; 
(medium NOES), and to d -0.6 &+0.8 A for distance constraints 
3.7-4.5 A (weak-medium and weak NOES) [25]. All protons were ex- 
plicitly defined in the dynamical simulated annealing calculations, in 
some cases, however, additional terms were added to the upper bounds 
that correspond to the pseudoatom correction introduced by Wiithrich 
12al. 
Table 1 
Chemical shifts (ppm) of LDTI-C at 27°C and pH 3.5 
Residue NH C?H 
Lys-1 
Lys-2 8.73 
4.66 
4.34 
C&I Others 
1.75 r-CH, 1.18: &CH, 1.31: e-CH, 3.01 
1.76 
1.97 
3.11, 2.88 
1.23 
3.06, 2.56+ 
2.07, 1.98 
1.86 
1.66 
1.73, 1.22’ 
1.72’, 1569 
1.91, 1.85 
2.19 
3.08+, 2.59 
j-CH; 1.38; S-CH; 1.72; E-CH; 2.86 
y-CHa 1.10, 0.89+ va1-3 
cys-4 
Ala-5 
Cys-6 
Pro-7 
Lys-8 
Ile-9 
Leu-10 
Lys- 11 
Pro-12 
Val-13 
cys-14 
Gly-15 
Ser-16 
Asp-17 
Gly-18 
8.41 4.08 
8.64 4.00 
8.72 
7.86 
4.50 
5.33 
4.52 y-CH* 2.38, 1.78; &CH, 3.92, 3.53 
yCH, 1.36; S-CH, 1.63; E-CH, 2.80 
y-CH2 1.38, 1.02; y-CH, 0.86; S-CH2 0.83 
y-CH 1.44; &CHs 0.84 
y-CH, 1.44, &CH, 1.70; E-CH, 2.92 
y-CH2 2.04, 1.50; 6-CH2 3.63, 3.36 
^/-CHg 0.99, 0.57’ 
8.72 
6.88 
8.65 
8.87 
4.26 
4.11 
4.64 
4.54 
4.62 
4.73 
5.25 
4.24, 4.76 
8.32 
8.79 
9.77 
9.02 4.02. 
8.46 4.46 
3.32 
2.95+, 2.64 
8.36 3.72, 4.04 
Arg-19 7.74 4.41 
Thr-20 8.29 4.99 
1.75, 1.31 
3.91 
2.84+, 2.42 
1.40 
3.37, 3.01’ 
3.36 
3.4, 3.07’ 
1.83 
0.90 
1.89, 1.73 
3.52, 3.32 
2.88, 2.46’ 
y-CHI 1 .18; &CH, 2.92 
y-CH3 1.10 
C2,6H 6.91; C3,5H 7.15 
^/-NH, 6.42/7.95 
1.91 
3.82 
1.78 
1.62, 1.42+ 
3.86+. 3.81 
2.11, 1.9+ 
y-CH, 0.91, y-CH, 1.18 
y-CH, 1.60, 6-CH2 3.15 
y-NH2 7.4917.37 
y-NH3 0.91, 0.64 
y-CHI 1.39/0.81; y-CH, 0.98; 6-CH, 0.69 
r-CH2 1.30; S-CH, 140; s-CH, 3.12 
y-CHI 2.27, 2.36 
3.72 
3.08, 2.48 
2.00, 1.91 
4.18 
y-CH2 3.7412.27; 6-CH2 3.59 
y-CH3 1.15 
1.78 y-CH2 1.37/1.09; y-CH, 0.83; 6-CH, 0.76 
1.55 &CH, 0.7910.86 
Tyr-21 
Ala-22 
Asn-23 
Ser-24 
Cys-25 
Ile-26 
Ala-27 
Arg-28 
Cys-29 
Asn-30 
Gly-3 1 
Val-32 
Ser-33 
Ile-34 
Lys-35 
Ser-36 
Glu-37 
Gly-38 
Ser-39 
cys-40 
Pro-41 
Thr-42 
Gly-43 
Ile-44 
Leu-45 
Asn-46 
9.20 4.57 
8.92 3.87 
7.15 4.94 
9.52 3.94 
8.07 4.21 
8.25 3.63 
7.37 2.82 
7.91 3.99 
8.56 4.16 
7.46 4.57 
7.96 
7.34 
8.04 
8.59 
9.24 
7.76 
8.61 
8.10 
7.82 
8.41 
_ 
8.18 
8.31 
7.91 
8.29 
7.23 
3.98, 3,78 
4.27 
4.43 
3.92 
4.26 
4.53 
4.33 
4.25, 3.53 
4.14 
4.67 
4.45 
4.25 
3.91 
4.09 
4.36 
3.17 
+The chemical shifts of H”‘, Hflz, or Cy’H3 protons (IUPAC notation). 
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3. Results and discusdon 
The NMR spectra of LDTI were assigned with the conven- 
tional 2D NMR methods based on the following spectra: 
NOESY, TOCSY, and COSY [26]. Proton resonances of all 
backbone and side chain atoms were assigned with the excep- 
tion of the CL proton of residue 43 (Table 1). In general the 
spectra had few overlaps. The side-chain NH protons of argin- 
ines and lysines were not observed in the spectra. An example 
of the quality of the NOESY spectrum is shown in Fig. 1. There 
are three proline residues in the sequence, Pro-7, Pro-12 and 
Pro-41; all of them have trans-peptide bond conformations (as 
inferred from the presence of the CO’H(i)-cdH(i+ 1) cross-peaks 
in the NOESY D,O spectra). 
Fig. 2 summarizes the sequential and medium-range NOES 
between the NH protons and the NH, C’H and @H protons, 
observed in the NOESY spectra of LDTI-C. These NOES are 
the basis for the determination of the secondary structure of the 
protein [26]. For LDTI-C, examination of the pattern of the 
NOES suggests the presence of a helix-like structure between 
residue 24 and 29. Strong sequential NH(z)-NH(i+l) cross- 
peaks, typical for helices, were found in the spectra. Addition- 
ally, NH(i)-NH(i+2) or C?H(z)-NH(i+3) connectivities were 
observed. However, the CaH(z)-NH(i+4) and the C”H(z)- 
@H(i+3) cross-peaks, which are necessary to characterize this 
helix as a a-helix, were missing. On the other hand, the C”H(i)- 
NH(i+2) cross-peaks, typical for a 3,0-helix, were present. For 
a regular 3,0-helix, however, one should also observe weak 
CaH(+@H(i+3) cross-peaks, which as mentioned above are 
not observed. This segment of the protein can then be best 
described as a 3,,-helix-loop. 
LDTI-C contains 6 cysteine residues and thus 3 disulfide 
bridges are possible. Based on the homology of LDTI-C to 
ovomucoid 3rd domain and other Kazal inhibitors, we pre- 
dicted disulfide pairing between Cys-4--Cys-29, Cys-6-Cys-25, 
and Cys-lCCys-40. This combination was indeed confirmed 
by NOE contacts among the CFH and C”H protons of corre- 
sponding cysteine residues in the disulfide bridges. Since, how- 
3.6 
3.8 
4.2 
4.6 
4.8 
8.4 8.2 8.0 F, @pm) 
Fig. 1. The NH-CaH region of 2D NOESY spectrum of LDTI-C. Intraresidue cross-peaks are labeled with one-letter abbreviations and interresidue 
connectivities are indicated by simple numbers. The intraresidue cross-peaks of K2 and C4 are circled at positions corresponding to the TOCSY 
NH-C”H cross-peaks. 
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3JkY-NH 
d,,(i,i+ 1) 
d,(i,i+ 1) 
d,(i,i+l) 
d,,(i,i+2) 
d,(i,i+2) 
d,(i,i+3) 
l a* l 0 l eee l eeeee l l 
78 &5 9 158118 105 69 x) 11 66655912x)88978 5 710 
Fig. 2. Amino acid sequence of LDTI-C and survey of NMR data used for identifying secondary structure. The NOES ((Cjl < 5), classified as weak, 
medium, strong, and very strong, are represented by the heights of the bars and were extracted from the NOISY spectra with mixing times of 100 
ms. The (?H(NH)(z)-C?H(i+l) (Pro) NOE is shown along the same line as the CQH(NH)(z)-NH(i+l) connectivities. Filled circles indicate NHs that 
did not exchange against D,O after 6 h. The values of the JtiuNH coupling constants (in Hz) are indicated below the sequence. The disulfide pairing 
is C4-C29, C6-C25 an C14-C40. 
0 1,,,,1,,,,I,,,,l,,,,i,,,,I,,,,l,,,,l,,,,I,,,,/, 
0 5 10 15 20 25 30 35 40 45 
Residue 
Fig. 3. Diagonal plot of the non-sequential interproton distance constraints used as input in the calculations. Backbone-backbone interactions (tilled 
squares) are plotted above the diagonal; backbone-side chain (circles) and side chain-side chain (squares) constraints are shown below the diagonal. 
294 El Mtilhahn et al. IFEBS Letters 355 (1994) 290-296 
ever, Cys-4 and Cysd are close to each other, the initial struc- 
tures were calculated without the presence of the disulfide 
bridges, i.e. no corresponding disulfide distance constraints nor 
S-S bonds were introduced in the calculations [25]. These strut- 
tures also indicated the predicted disulflde pairing and in the 
final calculations the S-S bridges were treated as normal bonds. 
The three-dimensional structure of LDTI-C was calculated 
from 262 approximate inter-residue distance constraints (no in- 
traresidue constraints were used). This number of constraints 
corresponds to the almost complete assignment of all cross- 
peaks in the NOESY spectra. A total of 20 structures were . 
calculated by a hybrid distance geometry-simulated annealing 
method [25] with the program XPLOR 3.1 [28]. Fig. 3 shows 
a diagonal plot of the NOES identified in the LDTI-C NOESY 
spectra. It can be seen that due to a large number of NOES the 
global folding of the peptide chain in the core is uniquely 
definied (Figs. 3,4). An average number of interresidue con- 
straints per residue in the core of the protein was 18. All struc- 
tures satisfy the experimental constraints (r.m.s. for residual 
NOE and dihedral constraint violations were 0.061 A and 
0.83”, respectively) with small deviations from idealized cova- 
lent geometry. The average atomic r.m.s. difference for heavy 
atoms in the core of LTDI (residues 4-34) among the structures 
was 0.4 f 0.1 A for the backbone atoms and 1.1 f 0.3 A for all 
atoms. The average r.m.s. difference between pairs of the struc- 
tures [25] in the 4, v, angles was < 25” and <40”, respectively. 
Larger r.m.s. differences were observed for the C- and N-termi- 
nus (ca. 3 A for the backbone atoms). 
Fig. 4 indicates that the backbone of LDTI-C is well deter- 
mined with the exception of residues l-3 and the C-termini 
residues from 41-46. These two regions of the protein seem to 
be completely unstructured. There were no long-range NOES 
observed for these regions, and the sequential NOES were much 
weaker than NOES of the residues in the core of the protein. 
Also, the TOCSY peaks were stronger with noticeable reduc- 
tion in the linewidths compared to the peaks of residues in well 
structured regions. 
The topology of the global fold of LDTI-C and its secondary 
A 
B 
Fig. 4. (A) Stereo view of the backbone atoms (N, Ccc, C, and 0) of LDTI-C structures best fitted to N, Ca, and C atoms of the residues 12-29. 
(B) Stereo picture of Ca tracing of LTDI with side chains of residues in the core. 
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Fig. 5. (A) Ribbon drawing of LDTI-C showing secondary structure and disulfide bridges. (R) Set of the structures that exhibit he canonical 
conformation of the binding loop (residues 6-12). 
structure elements are shown in Fig. 5A. The core of LDTI-C 
consists of a short one and a half-turn 3,,-helix-loop and an 
extended strand between Asn30 and Val-32 followed by a loop 
between Ser-33 and Cys-40. A fragment from Val-13 to Ala-22 
may be described as a interstrand connectivity similar to a 
mini-/?-sheet with a reversal at residue 15-19 (Fig. 5A). The 
strong Cys-14(CaH)-Thr-20(CaH) NOE and the medium Val- 
13(NH)-Tyr-Zl(NH) NOE is in agreement with such a descrip- 
tion. 
In general, the conformation of the side-chains are also well 
defined. Fig. 4B shows that only the side-chain of residues 8, 
19 and 28 have greater r.m.s. differences. This may be caused 
by the inability to make stereospecific assignments for these 
side-chain protons. A second reason is the lack of side-chain/ 
side-chain contacts (Fig. 3) and long-range NOES for these 
residues which makes it impossible to fix the side-chain of these 
residues. 
The N-terminus, which is connected to the helix via two 
disulfide-bridges, consists of the binding loop between residues 
6-12. Residues 4-10 show greater variability compared to the 
core of LDTI-C in the 20 final structures, which is evident in 
Fig. 4. This variability is due to the lack of non-sequential 
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NOES in this region (as seen in Fig. 3). Only residue Ile-9 has 
long range contacts to the core of the protein. Thus this region 
of the strand is connected to the core exclusively via the disul- 
fide-bridges and residue Ile-9. There was, however, a set of 
structures with a conformation of the binding loop shown in 
Fig. 5B. Although in no structures were there violations of the 
NOES larger than 0.4 A for loop residues, structures in Fig. 5B 
best fulfilled all the NOE and (especially) dihedral constraints. 
This is reminiscent of the situation found in conformations of 
the binding loop of CMTI-I [29]. In the case of CMTI-I, how- 
ever, it was possible to choose a unique conformation of the 
trypsin binding loop from a family of different conformations 
because only this conformation matched the relative pattern of 
NOES. For LDTI-C, other conformations of the binding loop 
fit the pattern of NOES in the loop, although most can be 
eliminated due to unfavorable 49 angles (4 and v, angles were 
for Pro-7 -85 + 5’ and 65 + 15”, Lys-8 -130 f 20” and 
20 f. 45”, Ile-9 -115 + 25” and 120 f 40”, Leu-10 -120 + 20” 
and 40 f 25”, respectively. For the conformations of Fig. 5B 
these angles were: Pro-7 -70 + 1” and 143 + 3”, Lys-8 
-114 f 2” and 45 f 5”, Ile-9 -75 f lo and 173 + 3”, Leu-10 
-92 + 1” and 62 + 2”, respectively). 
The best fit conformation of the binding loop corresponds 
to the ‘canonical conformation’, a conformation of the residues 
surrounding the scissile bond (residues P3-P3’) which is highly 
conserved among serine proteinase inhibitors [ 15,291 and which 
enables binding to the target protease. In LDTI-C, the follow- 
ing residues comprise this canonical loop: Cysd (P3), Pro-7 
(P2), Lys-8 (Pl), Ile-9 (Pl’), Leu-10 (P2’), and Lys-11 (P3’). 
Lys-8, at position Pl, is the primary determinant of specificity 
of the inhibitor, consistent with trypsin inhibition, and though 
disordered, is exposed and poised for insertion into the specific- 
ity pocket [15]. A proline residue is found at position P2 also 
in CMTI [29] and ovomucoid inhibitors [15] and in all cases 
adopts the canonical conformation. 
Prior to this structure determination, analysis of the interac- 
tions of LDTI with tryptase relied on modelled structures, 
which in turn were based on’the assumption of the ‘canonical 
conformation’ of the binding loop, on the disulfide bridge pat- 
tern of Kazal-type inhibitors, and on the modelled structure of 
bdellin [14]. LDTI and bdellin have a high similarity (55%), and 
may be aligned without gap insertion, so the model of LDTI 
differed from bdellin essentially only in the minimized positions 
of the side chains. Both models are very similar to the NMR 
structure in their overall fold and are generally confirmed by 
the NMR structures. The major difference is the flexibility seen 
at both termini. The termini are near the binding loop, and so 
may interact in unpredictable ways with tryptase or other target 
enzymes. Such interactions may contribute to the specificity of 
binding to tryptase, which, for example, is inhibited by LDTI 
but not bdellin. Further specificity may arise from interactions 
with insertions in loops adjacent to the reactive center, whose 
structures are not known. 
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